In vivo magnetic resonance imaging of-large spontaneous aortic aneurysms in old apolipoprotein E-deficient mice

Investigative Radiology

Volumn 39, Issue 10, 2004, Pages 585-590

  McFadden, Eugène P ^a,b   Chaabane, Linda ^a   Contard, Francis ^c   Guerrier, Daniel ^c   Briguet, André ^a   Douek, Philippe ^b   Soulas, Emmanuelle Canet ^b,d  

^a CPE LYON   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c Service de Physiopathologie Animale   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Aneurysms; Apolipoprotein E knockout mice; Atherosclerosis; Magnetic resonance imaging; Remodeling

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ANEURYSM; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; FEMALE; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 4644374038     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000138089.98165.88     Document Type: Article

References (27)

1. Fayad ZA, Fallon JT, Shinnar M, et al. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998;98:1541-1547.
2. Chaabane L, Canet E, Serfaty JM, et al. Microimaging of atherosclerotic plaque in animal models. Magma. 2000;11:58-60.
3. Choudhury RP, Aguinaldo JG, Rong JX, et al. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. Atherosclerosis. 2002;162:315-321.
4. Hockings PD, Roberts T, Galloway GJ, et al. Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation. 2002;106:1716-1721.
5. Itskovich VV, Choudhury RP, Aguinaldo JG, et al. Characterization of aortic root atherosclerosis in ApoE knockout mice: high-resolution in vivo and ex vivo MRM with histological correlation. Magn Reson Med. 2003;49:381-385.
6. Wiesmann F, Szimtenings M, Frydrychowicz A, et al. High-resolution MRI with cardiac and respiratory gating allows for accurate in vivo atherosclerotic plaque visualization in the murine aortic arch. Magn Reson Med. 2003;50:69-74.
7. Zhang SH, Reddick RL, Piedrahita JA, et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
8. Nakashima Y, Plump AS, Raines EW, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
9. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605-1612.
10. Daugherty A, Manning MW, Cassis LA. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol. 2001;134:865-870.
11. Chen J, Kuhlencordt PJ, Astern J, et al. Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein E/endothelial nitric oxide synthase double knockout mice. Circulation. 2001;104:2391-2394.
12. Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001;104:448-454.
13. Lutgens E, de Muinck ED, Heeneman S, et al. Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol. 2001;21:1359-1365.
14. Itskovich W, Lieb M, Aguinaldo JG, et al. Magnetic resonance microscopy quantifies the disease progression in Marfan syndrome mice. J Magn Reson Imaging. 2003;17:435-439.
15. Chaabane L, Soulas EC, Contard F, et al. High-resolution magnetic resonance imaging at 2 Tesla: potential for atherosclerotic lesions exploration in the apolipoprotein E knockout mouse. Invest Radiol. 2003;38:532-538.
16. Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997;17:439-444.
17. Johnston KW, Rutherford RB, Tilson MD, et al. Suggested standards for reporting on arterial aneurysms: Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1991;13:452-458.
18. O'Gara PT. Cardiology patient page: aortic aneurysm. Circulation. 2003;107:e43-45.
19. Virmani R, Robinowitz M, Atkinson JB, et al. Acquired coronary arterial aneurysms: an autopsy study of 52 patients. Hum Pathol. 1986;17:575-583.
20. Chen J, Tung CH, Mahmood U, et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 2002;105:2766-2771.
21. Lemaitre V, Soloway PD, D'Armiento J. Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1. Circulation. 2003;107:333-338.
22. Lijnen HR. Extracellular proteolysis in the development and progression of atherosclerosis. Biochem Soc Trans. 2002;30:163-167.
23. Longo GM, Xiong W, Greiner TC, et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625-632.
24. Silence J, Collen D, Lijnen HR. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res. 2002;90:897-903.
25. Moreno PR, Purushothaman KR, Fuster V, et al. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation. 2002;105:2504-2511.
26. Choudhury RP, Fayad ZA, Aguinaldo JG, et al. Serial, noninvasive, in vivo magnetic resonance microscopy detects the development of atherosclerosis in apolipoprotein E-deficient mice and its progression by arterial wall remodeling. J Magn Reson Imaging. 2003;17:184-189.
27. Wickline SA, Lanza GM. Nanotechnology for molecular imaging and targeted therapy. Circulation. 2003;107:1092-1095.